|
US5962030A
(en)
|
1997-03-07 |
1999-10-05 |
Akesis Pharmaceuticals, Inc. |
Dietary supplement and method of treatment for diabetic control
|
|
GB9715444D0
(en)
*
|
1997-07-22 |
1997-09-24 |
Scotia Holdings Plc |
Therapeutic and dietary compositions
|
|
IT1302125B1
(it)
*
|
1998-08-03 |
2000-07-31 |
Sigma Tau Healthscience Spa |
Composizione ad attivita' antiossidante ed antiproliferativacomprendente una carnitina ed un carotenoide
|
|
IT1302307B1
(it)
|
1998-09-01 |
2000-09-05 |
Sigma Tau Healthscience Spa |
Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
|
|
CA2344246A1
(en)
|
1998-09-17 |
2000-03-23 |
Akesis Pharmaceuticals, Inc. |
Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
|
|
US6376549B1
(en)
|
1998-09-17 |
2002-04-23 |
Akesis Pharmaceuticals, Inc. |
Metforimin-containing compositions for the treatment of diabetes
|
|
IT1302365B1
(it)
|
1998-10-09 |
2000-09-05 |
Sigma Tau Healthscience Spa |
Uso di carnitine e resveratrolo per produrre una composizione per laprevenzione o il trattamento terapeutico di alterazioni cerebrali
|
|
IT1306130B1
(it)
*
|
1999-04-16 |
2001-05-30 |
Sigma Tau Healthscience Spa |
Composizione comprendente una carnitina e glutatione, atta adaumentare l'assorbimento del glutatione sinergizzandone gli effetti.
|
|
IT1306133B1
(it)
*
|
1999-04-22 |
2001-05-30 |
Sigma Tau Healthscience Spa |
Composizione comprendente una carnitina ed un inositolfosfato, utilequale integratore dietetico o medicamento.
|
|
IT1306179B1
(it)
|
1999-07-28 |
2001-05-30 |
Sigma Tau Healthscience Spa |
Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
|
|
HK1047889B
(en)
*
|
1999-09-03 |
2009-04-09 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Ultrafine l-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same
|
|
IT1316998B1
(it)
*
|
2000-03-02 |
2003-05-26 |
Sigma Tau Healthscience Spa |
Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
|
|
IT1316997B1
(it)
*
|
2000-03-02 |
2003-05-26 |
Sigma Tau Healthscience Spa |
Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10.
|
|
WO2002009693A1
(en)
*
|
2000-08-02 |
2002-02-07 |
Pharmanutrients |
Method and compositions for prevention and/or treatment of diabetes and glucose modulation
|
|
US8669282B2
(en)
|
2000-10-31 |
2014-03-11 |
Hill's Pet Nutrition, Inc. |
Companion animal compositions including lipoic acid and methods of use thereof
|
|
US20020076470A1
(en)
|
2000-10-31 |
2002-06-20 |
Colgate-Palmolive Company |
Composition and method
|
|
US20020098247A1
(en)
*
|
2000-11-02 |
2002-07-25 |
Komorowski James R. |
Methods and compositions for the improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes and alpha lipoic acid
|
|
AU2002236527A1
(en)
|
2000-11-30 |
2002-06-11 |
The Health Research Institute |
Nutrient supplements and methods for treating autism and for preventing the onset of autism
|
|
US6555573B2
(en)
|
2000-12-21 |
2003-04-29 |
The Quigley Corporation |
Method and composition for the topical treatment of diabetic neuropathy
|
|
US20060062864A1
(en)
*
|
2000-12-28 |
2006-03-23 |
Mccleary Edward L |
Weight loss composition and method
|
|
US20040043013A1
(en)
|
2000-12-28 |
2004-03-04 |
Mccleary Edward Larry |
Metabolic uncoupling therapy
|
|
ITBS20010027A1
(it)
*
|
2001-03-23 |
2002-09-23 |
Gen Topics Srl |
Principio attivo a base di acido lipoico ed acidi grassi polienolici
|
|
US6964969B2
(en)
|
2001-04-19 |
2005-11-15 |
Mccleary Edward Larry |
Composition and method for treating impaired or deteriorating neurological function
|
|
US20060014773A1
(en)
*
|
2001-04-19 |
2006-01-19 |
Mccleary Edward L |
Mental agility lozenge, edible strip, food or drink
|
|
JP2002348244A
(ja)
*
|
2001-05-23 |
2002-12-04 |
Fancl Corp |
抗糖尿病組成物
|
|
NZ533439A
(en)
*
|
2001-12-19 |
2006-06-30 |
The Quigley Corp |
Methods for the treatment of peripheral neural and vascular ailments using flavonoid compositions
|
|
ITMI20012732A1
(it)
*
|
2001-12-20 |
2003-06-20 |
Health Pharma S R L |
Integratore alimentare per neuropatici
|
|
TW200304372A
(en)
*
|
2002-03-20 |
2003-10-01 |
Kanegafuchi Chemical Ind |
Compositions for diabetes
|
|
WO2003079819A1
(en)
*
|
2002-03-27 |
2003-10-02 |
Anglo French Drugs And Industries Ltd. |
Dietary supplement composition and a process of manufacturing said composition
|
|
US6974592B2
(en)
*
|
2002-04-11 |
2005-12-13 |
Ocean Nutrition Canada Limited |
Encapsulated agglomeration of microcapsules and method for the preparation thereof
|
|
US7977049B2
(en)
*
|
2002-08-09 |
2011-07-12 |
President And Fellows Of Harvard College |
Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
|
|
SE526943C2
(sv)
*
|
2002-08-26 |
2005-11-22 |
Indevex Ab |
Födoämneskompositionsprodukt
|
|
JP4833553B2
(ja)
*
|
2002-11-04 |
2011-12-07 |
オーシャン・ニュートリション・カナダ・リミテッド |
複数の殻を有するマイクロカプセル及びそれらの調製方法
|
|
US7083813B2
(en)
|
2002-11-06 |
2006-08-01 |
The Quigley Corporation |
Methods for the treatment of peripheral neural and vascular ailments
|
|
US7776913B2
(en)
|
2002-12-13 |
2010-08-17 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Carnitines for treating or preventing disorders caused by andropause
|
|
US20060025337A1
(en)
*
|
2003-07-01 |
2006-02-02 |
President And Fellows Of Harvard College |
Sirtuin related therapeutics and diagnostics for neurodegenerative diseases
|
|
CA2529510A1
(en)
*
|
2003-07-01 |
2005-01-13 |
President And Fellows Of Harvard College |
Compositions for manipulating the lifespan and stress response of cells and organisms
|
|
CA2436650A1
(en)
*
|
2003-08-06 |
2005-02-06 |
Naturia Inc. |
Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
|
|
US20050202063A1
(en)
*
|
2003-08-26 |
2005-09-15 |
Ebn International Kft |
Food product
|
|
US7875291B1
(en)
|
2003-09-05 |
2011-01-25 |
Glu-Pro, Inc. |
Composition for managing diabetes, obesity, and hyperlipidemia and associated methods
|
|
EP1537896B1
(de)
*
|
2003-12-03 |
2008-04-02 |
Franz-Peter Dr. Liebel |
Stoffgemische basierend auf schwefelhaltigen Aminosäuren, Antioxidantien, Phospholipiden und Vitaminen zur Herstellung eines Arzneimittels für die Behandlung des L-Diabetes und/oder assoziierter Erkrankungen
|
|
EP1708689A2
(en)
|
2003-12-29 |
2006-10-11 |
The President and Fellows of Harvard College |
Compositions for treating or preventing obesity and insulin resistance disorders
|
|
US8017634B2
(en)
|
2003-12-29 |
2011-09-13 |
President And Fellows Of Harvard College |
Compositions for treating obesity and insulin resistance disorders
|
|
EP1706146B1
(en)
*
|
2003-12-31 |
2013-08-21 |
K-Pax Pharmaceuticals, Inc. |
Nutrient compositions and use thereof for enhanced effectiveness of the immune system
|
|
JP2007519678A
(ja)
*
|
2004-01-28 |
2007-07-19 |
ネステク ソシエテ アノニム |
皮膚状態を改良しそして皮膚病を予防するための栄養組成物
|
|
ES2390075T3
(es)
|
2004-03-19 |
2012-11-06 |
Institut Pasteur |
Péptidos derivados de la proteína BPLP humana, polinucleótidos que codifican dichos péptidos y anticuerpos dirigidos contra dichos péptidos
|
|
US20050232911A1
(en)
*
|
2004-04-19 |
2005-10-20 |
Schreiber Brian D |
Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
|
|
WO2006007411A2
(en)
*
|
2004-06-16 |
2006-01-19 |
President And Fellows Of Harvard College |
Methods and compositions for modulating bax-mediated apoptosis
|
|
US20070244202A1
(en)
*
|
2004-06-28 |
2007-10-18 |
Kao Corporation |
Ampk Activator
|
|
US20060014705A1
(en)
*
|
2004-06-30 |
2006-01-19 |
Howitz Konrad T |
Compositions and methods for selectively activating human sirtuins
|
|
ITRM20040395A1
(it)
*
|
2004-08-03 |
2004-11-03 |
Sigma Tau Ind Farmaceuti |
Composizione comprendente statine e acidi grassi omega 3.
|
|
US7709539B2
(en)
*
|
2004-08-11 |
2010-05-04 |
Chang Gung University |
Therapeutic use of resveratrol for hyperglycemia
|
|
DK1830883T3
(da)
|
2004-12-29 |
2013-11-25 |
Hills Pet Nutrition Inc |
Fremgangsmåde til at hæmme en nedgang i indlæring og/eller hukommelse hos dyr
|
|
US8034450B2
(en)
*
|
2005-01-21 |
2011-10-11 |
Ocean Nutrition Canada Limited |
Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof
|
|
WO2006117675A1
(en)
*
|
2005-01-27 |
2006-11-09 |
Ocean Nutrition Canada Ltd. |
Fatty acid-benzenediol derivatives and methods of making and using thereof
|
|
US20080206316A1
(en)
*
|
2005-01-27 |
2008-08-28 |
Colin Barrow |
Chromium-Fatty Acid Compounds and Methods of Making and Using Thereof
|
|
CA2598792A1
(en)
*
|
2005-03-02 |
2006-09-08 |
Metanomics Gmbh |
Process for the production of fine chemicals
|
|
WO2006138418A2
(en)
|
2005-06-14 |
2006-12-28 |
President And Fellows Of Harvard College |
Improvement of cognitive performance with sirtuin activators
|
|
US20070149466A1
(en)
*
|
2005-07-07 |
2007-06-28 |
Michael Milburn |
Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
|
|
US9968120B2
(en)
*
|
2006-05-17 |
2018-05-15 |
Dsm Nutritional Products Ag |
Homogenized formulations containing microcapsules and methods of making and using thereof
|
|
EP1906912B1
(en)
|
2005-07-14 |
2012-08-15 |
Hill's Pet Nutrition, Inc. |
Method for prolonging the life of animals
|
|
CN101232822B
(zh)
*
|
2005-07-29 |
2012-11-14 |
蒂马基金会 |
用于减缓乙醇代谢和用于降低乙醇诱导的疾病风险的组合物
|
|
WO2007016949A1
(en)
*
|
2005-07-29 |
2007-02-15 |
Matuschka-Greiffenclau Markus |
Composition for reducing the risc of alcohol induced neuropathy
|
|
JP2007126390A
(ja)
*
|
2005-11-02 |
2007-05-24 |
Mercian Corp |
血糖値低下剤
|
|
GB0606864D0
(en)
*
|
2006-04-05 |
2006-05-17 |
Univ Nottingham |
Increades fatty acid oxidation
|
|
EP2007224A2
(en)
*
|
2006-04-07 |
2008-12-31 |
Ocean Nutrition Canada Limited |
Emulsions and microcapsules with substances having low interfacial tension, methods of making and using thereof
|
|
US9308232B2
(en)
|
2006-06-05 |
2016-04-12 |
Keyview Labs, Inc. |
Compositions and methods for enhancing brain function
|
|
US10105406B2
(en)
|
2006-06-05 |
2018-10-23 |
Keyview Labs, Inc. |
Compositions and methods for enhancing brain function using acetyl-L-carnitine, huperzine A, Ginkgo biloba, and vitamin B complex
|
|
EP2040682B1
(en)
*
|
2006-06-05 |
2017-07-26 |
DSM Nutritional Products AG |
Microcapsules with improved shells
|
|
US8071610B2
(en)
*
|
2006-06-05 |
2011-12-06 |
Josh Reynolds |
Compositions and methods for enhancing brain function
|
|
US10105405B2
(en)
|
2006-06-05 |
2018-10-23 |
Keyview Labs, Inc. |
Compositions and methods for enhancing brain function using acetyl-L-carnitine, huperzine A and ginkgo biloba
|
|
US20070281961A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Brite Age |
Modified Compositions And Methods For Enhancing Brain Function
|
|
US8883814B2
(en)
|
2006-06-05 |
2014-11-11 |
Keyview Labs, Inc. |
Compositions and methods for enhancing brain function
|
|
ES2604081T3
(es)
|
2007-01-10 |
2017-03-02 |
Dsm Nutritional Products Ag |
Microcápsulas que incluyen proteína de guisante
|
|
US20080226696A1
(en)
*
|
2007-03-15 |
2008-09-18 |
Ben Treadwell |
Methods of improving learning abilities of aged companion animals
|
|
NZ579767A
(en)
*
|
2007-03-21 |
2012-04-27 |
Sigma Tau Ind Farmaceuti |
Acetyl L-carnitine, optionally combined with an antihypertensive drug or a statin, for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance
|
|
WO2008141897A1
(en)
*
|
2007-05-24 |
2008-11-27 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Composition useful for the prevention of adverse effect due to the use of ppar-gamma agonists
|
|
AU2010247800A1
(en)
|
2009-05-11 |
2011-12-15 |
Berg Llc |
Methods for the diagnosis of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
|
|
US20120053437A1
(en)
*
|
2010-08-25 |
2012-03-01 |
Hickle Randall S |
Monitored healthcare process for the treatment of specific health problems with medical foods and/or drugs
|
|
CA2832324C
(en)
|
2011-04-04 |
2022-03-15 |
Berg Llc |
Methods of treating central nervous system tumors
|
|
US9040082B2
(en)
|
2011-06-24 |
2015-05-26 |
K-Pax Pharmaceuticals, Inc. |
Compositions and methods for treatment of chronic fatigue
|
|
US8623924B2
(en)
|
2011-07-15 |
2014-01-07 |
Nusirt Sciences, Inc. |
Compositions and methods for modulating metabolic pathways
|
|
US9198454B2
(en)
|
2012-03-08 |
2015-12-01 |
Nusirt Sciences, Inc. |
Compositions, methods, and kits for regulating energy metabolism
|
|
MX2015006023A
(es)
|
2012-11-13 |
2016-03-31 |
Nusirt Sciences Inc |
Composiciones y metodos para incrementar el metabolismo energetico.
|
|
CN105228627B
(zh)
|
2013-03-15 |
2018-07-13 |
纽斯尔特科学公司 |
亮氨酸和烟酸降低脂质水平
|
|
SG10201903112WA
(en)
|
2013-04-08 |
2019-05-30 |
Berg Llc |
Treatment of cancer using coenzyme q10 combination therapies
|
|
KR102370843B1
(ko)
|
2013-09-04 |
2022-03-04 |
버그 엘엘씨 |
코엔자임 q10의 연속주입에 의한 암치료 방법
|
|
EP3110507B1
(en)
|
2014-02-27 |
2020-11-18 |
NuSirt Sciences, Inc. |
Compositions and methods for the reduction or prevention of hepatic steatosis
|
|
CN111768837A
(zh)
|
2014-04-28 |
2020-10-13 |
耶达研究及发展有限公司 |
用于预测对食物的反应的方法和装置
|
|
EP3289093A4
(en)
*
|
2015-04-28 |
2019-04-17 |
Yeda Research and Development Co., Ltd. |
USE OF MICROBIAL METABOLITES FOR THE TREATMENT OF DISEASES
|
|
WO2017087576A1
(en)
|
2015-11-16 |
2017-05-26 |
Berg Llc |
Methods of treatment of temozolomide-resistant glioma using coenzyme q10
|
|
CN108378355A
(zh)
*
|
2018-01-06 |
2018-08-10 |
福建古瑞森生物科技有限公司 |
降低2型糖尿病患者餐后血糖改善血脂增加肠道有益菌的餐前预营养组合物及其制备方法
|